表紙:代謝アッセイ市場、シェア、市場規模、動向、産業分析レポート:製品別、用途別、エンドユーザー別、地域別、セグメント別予測、2023年~2032年
市場調査レポート
商品コード
1421696

代謝アッセイ市場、シェア、市場規模、動向、産業分析レポート:製品別、用途別、エンドユーザー別、地域別、セグメント別予測、2023年~2032年

Metabolism Assays Market Share, Size, Trends, Industry Analysis Report, By Product (Assay Kits and Reagents, Instruments and Analyzers); By Application; By End User; By Region; Segment Forecast, 2023- 2032

出版日: | 発行: Polaris Market Research | ページ情報: 英文 114 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.36円
代謝アッセイ市場、シェア、市場規模、動向、産業分析レポート:製品別、用途別、エンドユーザー別、地域別、セグメント別予測、2023年~2032年
出版日: 2023年11月23日
発行: Polaris Market Research
ページ情報: 英文 114 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、代謝アッセイの世界市場規模は2032年までに28億350万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

遠隔医療市場は、ヘルスケアが遠隔およびデジタルソリューションを取り入れるにつれて拡大しています。遠隔医療サービスには代謝モニタリングが含まれ、患者が自宅にいながら専門的なケアにアクセスできる機会を創出しています。遠隔医療が受け入れられつつあることで、より広範な代謝評価と診断が促進されています。

ポイント・オブ・ケア検査機器の急速な進歩は、市場拡大の機会を提供します。使いやすく、迅速で、手頃な価格の代謝検査機器の普及は、遠隔地や資源に制約のある環境にとって特に有益であり、代謝健康評価をより多くの人々に拡大します。

研究機関、製薬会社、アッセイメーカー間の協力的パートナーシップは、技術革新を促進し、新規代謝アッセイの開発を推進します。このような共同作業は、代謝研究の限界を押し広げるのに役立っています。

北米は2022年に大きな市場シェアを占めました。同地域では、臨床検査法および診断法に関する包括的な規制の枠組みが確立されています。この枠組みは、代謝アッセイが厳格な品質と安全性基準を遵守することを保証し、研究者とヘルスケア専門家の双方に信頼を提供しています。新興のバイオテクノロジークラスターは代謝研究の中心地となっています。このような拠点が代謝アッセイと関連技術の需要を促進し、市場全体を強化しています。米国市場の競争は、代謝アッセイの革新と多様性を促進しています。研究者や臨床医は、基礎研究から臨床診断まで多様なニーズに応える幅広いアッセイから恩恵を受けています。

新興市場、特にアジア太平洋とラテンアメリカは、代謝検査導入の未開拓の機会を提供しています。これらの地域では急速な都市化が進み、ヘルスケア・インフラが整備され、可処分所得が増加しているため、市場拡大のチャンスが広がっています。消費者の健康とウェルネスへの関心の高まりが、代謝検査とアッセイの需要を促進しています。個々人に合わせた健康管理に熱心であり、代謝測定は極めて重要な役割を果たしています。

代謝アッセイ市場レポートハイライト

薬物スクリーニング、毒性評価、代謝異常モニタリングの需要増により、アッセイキットおよび試薬分野が2022年に大きなシェアを占める

診断薬セグメントは2022年に最大の市場シェアを占めたが、これは主に疾患の早期発見、個別化治療、治療効果のモニタリングによる。

製薬・バイオ製薬企業セグメントは、主に創薬と検証、安全性プロファイリング、規制遵守における使用により、2022年に最大の市場収益シェアを占めました。

北米地域は、研究・学術機関、製薬・バイオテクノロジー企業、政府助成金の存在により、2022年の市場シェアの大半を占めました。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の代謝アッセイ市場の洞察

  • 代謝アッセイ市場- エンドユーザーのスナップショット
  • 代謝アッセイの市場力学
    • 促進要因と機会
      • 慢性疾患の増加
      • 製薬会社からの需要拡大
    • 抑制要因と課題
      • 高度なアッセイの高コスト
  • PESTEL分析
  • 代謝アッセイ市場のエンドユーザー動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の代謝アッセイ市場、製品別

  • 主な調査結果
  • イントロダクション
  • アッセイキットと試薬
  • 機器と分析装置

第6章 世界の代謝アッセイ市場、用途別

  • 主な調査結果
  • イントロダクション
  • 研究
  • 診断

第7章 世界の代謝アッセイ市場、エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 病院
  • 診断ラボ
  • 製薬会社およびバイオ医薬品会社
  • その他

第8章 世界の代謝アッセイ市場、地域別

  • 主な調査結果
  • イントロダクション
    • 代謝アッセイ市場評価、地域、2019-2032年
  • 代謝アッセイ市場-北米
    • 北米:代謝アッセイ市場、製品別、2019-2032年
    • 北米:代謝アッセイ市場、エンドユーザー別、2019~2032年
    • 北米:代謝アッセイ市場、用途別、2019-2032年
    • 代謝アッセイ市場-米国
    • 代謝アッセイ市場- カナダ
  • 代謝アッセイ市場- 欧州
    • 欧州:代謝アッセイ市場、製品別、2019~2032年
    • 欧州:代謝アッセイ市場、エンドユーザー別、2019-2032
    • 欧州:代謝アッセイ市場、用途別、2019~2032年
    • 代謝アッセイ市場- 英国
    • 代謝アッセイ市場- フランス
    • 代謝アッセイ市場- ドイツ
    • 代謝アッセイ市場- イタリア
    • 代謝アッセイ市場- スペイン
    • 代謝アッセイ市場- オランダ
    • 代謝アッセイ市場- ロシア
  • 代謝アッセイ市場- アジア太平洋
    • アジア太平洋:代謝アッセイ市場、製品別、2019~2032年
    • アジア太平洋:代謝アッセイ市場、エンドユーザー別、2019~2032年
    • アジア太平洋:代謝アッセイ市場、用途別、2019~2032年
    • 代謝アッセイ市場- 中国
    • 代謝アッセイ市場- インド
    • 代謝アッセイ市場- マレーシア
    • 代謝アッセイ市場- 日本
    • 代謝アッセイ市場- インドネシア
    • 代謝アッセイ市場- 韓国
  • 代謝アッセイ市場-中東およびアフリカ
    • 中東およびアフリカ:代謝アッセイ市場、製品別、2019~2032年
    • 中東およびアフリカ:代謝アッセイ市場、エンドユーザー別、2019~2032年
    • 中東およびアフリカ:代謝アッセイ市場、用途別、2019~2032年
    • 代謝アッセイ市場- サウジアラビア
    • 代謝アッセイ市場- アラブ首長国連邦
    • 代謝アッセイ市場- イスラエル
    • 代謝アッセイ市場- 南アフリカ
  • 代謝アッセイ市場-ラテンアメリカ
    • ラテンアメリカ:代謝アッセイ市場、製品別、2019-2032年
    • ラテンアメリカ:代謝アッセイ市場、エンドユーザー別、2019-2032
    • ラテンアメリカ:代謝アッセイ市場、用途別、2019-2032年
    • 代謝アッセイ市場- メキシコ
    • 代謝アッセイ市場- ブラジル
    • 代謝アッセイ市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Abcam plc
  • .Agilent Technologies, Inc.
  • Becton, Dickinson and Company(BD)
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioLegend, Inc.
  • BioVision, Inc.
  • Cayman Chemical Company
  • Cell Biolabs, Inc.
  • Enzo Biochem, Inc.
  • G-Biosciences
  • Merck KGaA(MilliporeSigma)
  • PerkinElmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.
図表

List of Tables

  • Table 1 Global Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 2 Global Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 3 Global Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 4 Metabolism Assays Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 6 North America: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 7 North America: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 8 U.S.: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 9 U.S.: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 10 U.S.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 11 Canada: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 12 Canada: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 13 Canada: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 14 Europe: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 15 Europe: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 16 Europe: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 17 UK: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 18 UK: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 19 UK: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 20 France: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 21 France: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 22 France: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 23 Germany: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 24 Germany: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 25 Germany: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 26 Italy: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 27 Italy: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 28 Italy: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 29 Spain: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 30 Spain: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 31 Spain: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 32 Netherlands: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 33 Netherlands: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 34 Netherlands: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 35 Russia: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 36 Russia: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 37 Russia: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 41 China: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 42 China: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 43 China: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 44 India: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 45 India: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 46 India: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 47 Malaysia: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 48 Malaysia: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 49 Malaysia: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 50 Japan: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 51 Japan: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 52 Japan: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 53 Indonesia: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 54 Indonesia: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 55 Indonesia: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 56 South Korea: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 57 South Korea: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 58 South Korea: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 65 UAE: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 66 UAE: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 67 UAE: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 68 Israel: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 69 Israel: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 70 Israel: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 71 South Africa: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 72 South Africa: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 73 South Africa: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 74 Latin America: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 75 Latin America: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 76 Latin America: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 77 Mexico: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 78 Mexico: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 79 Mexico: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 80 Brazil: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 81 Brazil: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 82 Brazil: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • Table 83 Argentina: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • Table 84 Argentina: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • Table 85 Argentina: Metabolism Assays Market, by End User, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Metabolism Assays Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Metabolism Assays Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8. Market by Product
  • Figure 9. Global Metabolism Assays Market, by Product, 2022 & 2032 (USD Million)
  • Figure 10. Market by End User
  • Figure 11. Global Metabolism Assays Market, by End User, 2022 & 2032 (USD Million)
  • Figure 12. Metabolism Assays Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Metabolism Assays Market
目次
Product Code: PM4040

The global metabolism assays market size is expected to reach USD 2,803.50 million by 2032, according to a new study by Polaris Market Research. The report "Metabolism Assays Market Share, Size, Trends, Industry Analysis Report, By Product (Assay Kits and Reagents, Instruments and Analyzers); By Application; By End User; By Region; Segment Forecast, 2023- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The telemedicine market is expanding as healthcare embraces remote and digital solutions. Telehealth services encompass metabolic monitoring, creating opportunities for patients to access specialized care from the comfort of their homes. The growing acceptance of telemedicine is facilitating broader metabolic assessments and diagnostics.

Rapid advancements in point-of-care testing devices offer opportunities for the market to expand its reach. The proliferation of user-friendly, quick, and affordable metabolic testing devices is particularly beneficial for remote or resource-constrained settings, extending metabolic health assessments to a broader population.

Collaborative partnerships between research institutions, pharmaceutical firms, and assay manufacturers foster innovation and drive the development of novel metabolic assays. These collaborative efforts are instrumental in pushing the boundaries of metabolic research.

North America accounted for a significant market share in 2022. The region has established a comprehensive regulatory framework for clinical assays and diagnostics. This framework ensures that metabolism assays adhere to stringent quality and safety standards, providing confidence to both researchers and healthcare professionals. Emerging biotechnology clusters have become focal points for metabolic research. These hubs drive a demand for metabolic assays and related technologies, bolstering the overall market. The competitive nature of the U.S. market promotes innovation and diversity in metabolic assay offerings. Researchers and clinicians benefit from a wide range of assays that cater to diverse needs, from fundamental research to clinical diagnosis.

Emerging markets, especially in Asia-Pacific and Latin America, offer untapped opportunities for the adoption of metabolic testing. Rapid urbanization, growing healthcare infrastructure, and rising disposable incomes in these regions present opportunities for market expansion. The consumers' increasing focus on health and wellness is driving demand for metabolic testing and assays. Individuals are keen on personalized health management, and metabolism assays play a pivotal role.

Metabolism Assays Market Report Highlights

Assay kits and reagents segment held significant share in 2022, owing to increase in demand for drug screening, toxicology assessments, and monitoring of metabolic disorders

Diagnostics segment accounted for largest market share in 2022, which is mainly driven by early disease detection, personalized treatment, and monitoring treatment efficacy

Pharmaceutical and biopharmaceutical companies segment held the maximum market revenue share in 2022, mainly due use in drug discovery and validation, safety profiling, and regulatory adherence

North America region dominated the market with majority share in 2022, owing to presence of research and academic institutions, pharmaceutical and biotechnology companies, and government funding

The global key market players include: Abcam plc, Agilent Technologies, Inc., Merck KGaA (MilliporeSigma), PerkinElmer, Inc., Becton, Dickinson and Company (BD), and Thermo Fisher Scientific, Inc. among others

Polaris Market Research has segmented the Metabolism Assays market report based on product, application, end user, and region:

Metabolism Assays, Product Outlook (Revenue - USD Million, 2019 - 2032)

  • Assay Kits and Reagents
  • Instruments and Analyzers

Metabolism Assays, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Research
  • Diagnostics

Metabolism Assays, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Diagnostics Labs
  • Pharmaceutical and Biopharmaceutical Companies
  • Others

Metabolism Assays, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Metabolism Assays Market Insights

  • 4.1. Metabolism Assays Market - End User Snapshot
  • 4.2. Metabolism Assays Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rise in chronic conditions
      • 4.2.1.2. Greater demand from pharmaceutical companies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Advanced Assays
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Metabolism Assays Market End User Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Metabolism Assays Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Metabolism Assays Market, by Product, 2019-2032 (USD Million)
  • 5.3. Assay Kits and Reagents
    • 5.3.1. Global Metabolism Assays Market, by Assay Kits and Reagents, by Region, 2019-2032 (USD Million)
  • 5.4. Instruments and Analyzers
    • 5.4.1. Global Metabolism Assays Market, by Instruments and Analyzers, by Region, 2019-2032 (USD Million)

6. Global Metabolism Assays Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • 6.3. Research
    • 6.3.1. Global Metabolism Assays Market, by Research, by Region, 2019-2032 (USD Million)
  • 6.4. Diagnostics
    • 6.4.1. Global Metabolism Assays Market, by Diagnostics, by Region, 2019-2032 (USD Million)

7. Global Metabolism Assays Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Metabolism Assays Market, by End User, 2019-2032 (USD Million)
  • 7.3. Hospitals
    • 7.3.1. Global Metabolism Assays Market, by Hospitals, By Region, 2019-2032 (USD Million)
  • 7.4. Diagnostics Labs
    • 7.4.1. Global Metabolism Assays Market, by Diagnostics Labs, By Region, 2019-2032 (USD Million)
  • 7.5. Pharmaceutical and Biopharmaceutical Companies
    • 7.5.1. Global Metabolism Assays Market, by Pharmaceutical and Biopharmaceutical Companies, By Region, 2019-2032 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Metabolism Assays Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Metabolism Assays Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Metabolism Assays Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Metabolism Assays Market - North America
    • 8.3.1. North America: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
    • 8.3.2. North America: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
    • 8.3.3. North America: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.3.4. Metabolism Assays Market - U.S.
      • 8.3.4.1. U.S.: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.3.5. Metabolism Assays Market - Canada
      • 8.3.5.1. Canada: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • 8.4. Metabolism Assays Market - Europe
    • 8.4.1. Europe: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
    • 8.4.3. Europe: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.4.4. Metabolism Assays Market - UK
      • 8.4.4.1. UK: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.4.5. Metabolism Assays Market - France
      • 8.4.5.1. France: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.4.5.3. France: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.4.6. Metabolism Assays Market - Germany
      • 8.4.6.1. Germany: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.4.7. Metabolism Assays Market - Italy
      • 8.4.7.1. Italy: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.4.8. Metabolism Assays Market - Spain
      • 8.4.8.1. Spain: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.4.9. Metabolism Assays Market - Netherlands
      • 8.4.9.1. Netherlands: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.4.10. Metabolism Assays Market - Russia
      • 8.4.10.1. Russia: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • 8.5. Metabolism Assays Market - Asia Pacific
    • 8.5.1. Asia Pacific: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.5.4. Metabolism Assays Market - China
      • 8.5.4.1. China: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.5.4.3. China: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.5.5. Metabolism Assays Market - India
      • 8.5.5.1. India: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.5.5.3. India: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.5.6. Metabolism Assays Market - Malaysia
      • 8.5.6.1. Malaysia: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.5.7. Metabolism Assays Market - Japan
      • 8.5.7.1. Japan: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.5.8. Metabolism Assays Market - Indonesia
      • 8.5.8.1. Indonesia: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.5.9. Metabolism Assays Market - South Korea
      • 8.5.9.1. South Korea: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • 8.6. Metabolism Assays Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.6.4. Metabolism Assays Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.6.5. Metabolism Assays Market - UAE
      • 8.6.5.1. UAE: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.6.6. Metabolism Assays Market - Israel
      • 8.6.6.1. Israel: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.6.7. Metabolism Assays Market - South Africa
      • 8.6.7.1. South Africa: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
  • 8.7. Metabolism Assays Market - Latin America
    • 8.7.1. Latin America: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.7.4. Metabolism Assays Market - Mexico
      • 8.7.4.1. Mexico: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.7.5. Metabolism Assays Market - Brazil
      • 8.7.5.1. Brazil: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Metabolism Assays Market, by Application, 2019-2032 (USD Million)
    • 8.7.6. Metabolism Assays Market - Argentina
      • 8.7.6.1. Argentina: Metabolism Assays Market, by Product, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Metabolism Assays Market, by End User, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Metabolism Assays Market, by Application, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abcam plc
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. .Agilent Technologies, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Becton, Dickinson and Company (BD)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bio-Rad Laboratories, Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Bio-Techne Corporation
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. BioLegend, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. BioVision, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Cayman Chemical Company
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Cell Biolabs, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Enzo Biochem, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. G-Biosciences
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Merck KGaA (MilliporeSigma)
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. PerkinElmer, Inc.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Promega Corporation
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Thermo Fisher Scientific, Inc.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development